Application 761103
- Type
- BLA
- Sponsor
- PFIZER INC
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761103 | Ruxience | rituximab-pvvr | 351(k) Biosimilar | Rx | 2026-08-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | RUXIENCE | RITUXIMAB-PVVR | INJECTABLE;INJECTION | 100MG/10ML(10MG/ML) | No | No |
| 002 | RUXIENCE | RITUXIMAB-PVVR | INJECTABLE;INJECTION | 500MG/50ML(10MG/ML) | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ruxience | RITUXIMAB-PVVR | Pfizer Laboratories Div Pfizer Inc | f941fc61-f7a3-4e4a-ab7c-87c1667fa05b | 2026-08-26 | Boxed warning, Warnings, Adverse reactions | BLA761103 0069-0249 0069-0238 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0069-0238 | Ruxience | rituximab-pvvr | Pfizer Laboratories Div Pfizer Inc | BLA | Current |
| 0069-0238 | Ruxience | rituximab-pvvr | Pfizer Laboratories Div Pfizer Inc | BLA | Current |
| 0069-0238 | Ruxience | rituximab-pvvr | Pfizer Laboratories Div Pfizer Inc | BLA | Current |
| 0069-0249 | Ruxience | rituximab-pvvr | Pfizer Laboratories Div Pfizer Inc | BLA | Current |
| 0069-0249 | Ruxience | rituximab-pvvr | Pfizer Laboratories Div Pfizer Inc | BLA | Current |
| 0069-0249 | Ruxience | rituximab-pvvr | Pfizer Laboratories Div Pfizer Inc | BLA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 82525 | SUPPL | 2025-06-10 |
| 82524 | SUPPL | 2025-06-10 |
| 75866 | SUPPL | 2023-10-20 |
| 75831 | SUPPL | 2023-10-17 |
| 69336 | SUPPL | 2021-11-17 |
| 69321 | SUPPL | 2021-11-16 |
| 69320 | SUPPL | 2021-11-16 |
| 63330 | SUPPL | 2020-05-29 |
| 63307 | SUPPL | 2020-05-27 |
| 63306 | SUPPL | 2020-05-27 |
| 59773 | ORIG | 2019-08-20 |
| 59442 | ORIG | 2019-08-20 |
| 59406 | ORIG | 2019-07-23 |
| 59405 | ORIG | 2019-07-23 |